Get the Stockscreener App
50.38
0.78%
0.39
Hims Hers Health Inc stock is traded at $50.38, with a volume of 22.02M.
It is up +0.78% in the last 24 hours and down -17.50% over the past month.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
See More
Previous Close:
$49.99
Open:
$50.67
24h Volume:
22.02M
Relative Volume:
0.50
Market Cap:
$10.85B
Revenue:
$1.78B
Net Income/Loss:
$164.40M
P/E Ratio:
73.01
EPS:
0.69
Net Cash Flow:
$236.51M
1W Performance:
+5.20%
1M Performance:
-17.50%
6M Performance:
+80.90%
1Y Performance:
+147.32%
1-Day Range:
$48.50
$51.07
1-Week Range:
$47.36
$53.24
52-Week Range:
$13.47
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Name
Hims Hers Health Inc
Sector
Industry
Phone
415-851-0195
Address
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
50.38 | 10.72B | 1.78B | 164.40M | 236.51M | 0.69 |
|
PG
Procter Gamble Co
|
155.10 | 368.21B | 83.93B | 15.50B | 15.03B | 6.30 |
|
UL
Unilever Plc Adr
|
59.70 | 149.04B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
86.84 | 72.60B | 19.95B | 2.90B | 3.47B | 3.54 |
|
KMB
Kimberly Clark Corp
|
127.53 | 42.93B | 19.75B | 2.47B | 2.39B | 7.34 |
|
KVUE
Kenvue Inc
|
22.00 | 40.97B | 15.30B | 1.06B | 1.45B | 0.55 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-25 | Downgrade | Needham | Buy → Hold |
| Jun-04-25 | Reiterated | Needham | Buy |
| Apr-29-25 | Downgrade | TD Cowen | Buy → Hold |
| Feb-18-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-25 | Downgrade | Citigroup | Neutral → Sell |
| Jan-07-25 | Initiated | BTIG Research | Buy |
| Dec-17-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-22-24 | Initiated | Needham | Buy |
| Aug-09-24 | Downgrade | Imperial Capital | Outperform → In-line |
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Apr-16-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-10-24 | Initiated | Canaccord Genuity | Buy |
| Feb-28-24 | Upgrade | Imperial Capital | In-line → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | Imperial Capital | In-line |
| Jul-28-23 | Initiated | TD Cowen | Outperform |
| Apr-11-23 | Initiated | Robert W. Baird | Neutral |
| Feb-09-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-08-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-17-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-07-22 | Initiated | Truist | Hold |
| Jul-15-22 | Initiated | SVB Leerink | Underperform |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-10-22 | Initiated | Deutsche Bank | Hold |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Nov-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-06-21 | Initiated | BofA Securities | Neutral |
| May-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-21-21 | Initiated | Truist | Hold |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Mar-02-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Initiated | Citigroup | Neutral |
| Feb-12-21 | Initiated | Piper Sandler | Neutral |
| Feb-08-21 | Initiated | Tigress Financial | Buy |
View All
Hims Hers Health Inc Stock (HIMS) Latest News
How Hims & Hers Health Is Quietly Changing Healthcare (NYSE:HIMS) - Seeking Alpha
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims - Morningstar
Hims & Hers health CEO Dudum sells $2.5m in shares - Investing.com
HIMS Shareholder Reminder: Kessler Topaz Meltzer & Check, - GlobeNewswire
HIMS Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Hims & Hers Health, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit - GlobeNewswire Inc.
All You Need to Know About Hims & Hers Health (HIMS) Rating Upgrade to Strong Buy - Yahoo Finance
HIMS Investors Have the Opportunity to Lead the Hims & Hers Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - StreetInsider
HIMS ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Hims & Hers Health, Inc.August 25, 2025 Deadline - The Globe and Mail
HIMS SECURITIES FRAUD: Hims & Hers Health, Inc. (NYSE:HIMS) - GlobeNewswire
Weight-Loss Drugs Telehealth Platform Hims & Hers Hit With New Lawsuit - Newsweek
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Contact Levi & Korsinsky by August 25, 2025 Deadline to Join Class Action Against Hims & Hers Health, Inc.(HIMS) - PR Newswire
BofA Securities maintains Hims and Hers stock rating at Underperform By Investing.com - Investing.com Canada
Investors who lost money on Hims & Hers Health, Inc.(HIMS) - GlobeNewswire
Kessler Topaz Meltzer & Check, LLP Reminds HIMS Shareholders of Deadline in Securities Fraud Class Action Lawsuit Filed Against Hims & Hers Health, Inc. (HIMS) - The Malaysian Reserve
HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Hims & Hers Health, Inc. (HIMS) Alleged “Deceptive” - GlobeNewswire
Hims & Hers Stock Surges 90.4% in 3 Months: What's Fueling the Rally? - Yahoo Finance
Important Notice to Long-Term Shareholders of Centene - GlobeNewswire
Securities Fraud Class Action Filed Against Hims & Hers Health, Inc. (HIMS)Levi & Korsinsky Reminds Investors of August 25, 2025 - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesHIMS - PR Newswire
The Gross Law Firm Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025HIMS - PR Newswire
Hims & Hers Executives Face Lawsuit Over Knockoff Wegovy Sales - USA Herald
HIMS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Hims & Hers Health, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - GlobeNewswire Inc.
Hims & Hers Health, Inc. (HIMS) Alleged "Deceptive" Marketing of Wegovy Triggers Securities Class ActionsHIMS Investors with Losses Encouraged to Contact Hagens Berman - ACCESS Newswire
Hims & Hers Brass Face Suit Over 'Knockoff' Wegovy Sales - Law360
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Hims & - GlobeNewswire
Hims & Hers Health, Inc. Securities Fraud Class Action - GlobeNewswire
Hims & Hers (HIMS) Faces Legal Storm Post Novo Nordisk Breakup - TipRanks
DEADLINE ALERT for RDDT, HIMS, IRBT, and CNC: The Law - GlobeNewswire
HIMS INVESTOR NOTICE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - GlobeNewswire
Lawsuits rain down on Hims & Hers after Novo Nordisk partnership ends - medwatch.com
Hims & Hers Health Is Looking to Cash In on This Novo Nordisk Blunder - The Globe and Mail
Hims & Hers hit with growing number of investor lawsuits after Novo deal exit - Seeking Alpha
Securities Lawsuit Alert: Hims & Hers Health, Inc. (HIMS) InvestorsContact Levi & Korsinsky Before August 25, 2025 - ACCESS Newswire
Hims & Hers Health (HIMS) vs. Its Competitors Financial Analysis - Defense World
Hims & Hers: Navigating Regulatory Headwinds with Strategic Agility and Subscription Dominance - AInvest
Why Hims & Hers Management Might Be Its Most Valuable Asset - Seeking Alpha
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - GlobeNewswire Inc.
Hims & Hers hit with investor lawsuits after Novo ends Wegovy partnership - Reuters
Hims & Hers Health, Inc. (HIMS) Announces Expansion To Canada - MSN
Hims & Hers Health, Inc. (HIMS) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Hims & Hers health CLO Boughton Soleil sells $122993 in stock - Investing.com
Hims & Hers CFO Okupe sells $552k in shares - Investing.com
Hims & Hers Shareholder Sues Top Brass Over Wegovy Maker’s Drop - Bloomberg Law News
How Novo Nordisk Rival Hims Became King of Knockoff Weight-Loss Drugs - Bloomberg.com
Hims & Hers: A Strategic Powerhouse in the Health & AI Infrastructure Surge - AInvest
Hims Hers Health Inc Stock (HIMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.07%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):